Non-IgE mediated food allergy - update of recent progress in mucosal immunity

Inflammation and Allergy - Drug Targets

Volumn 11, Issue 5, 2012, Pages 382-396

  Jyonouchi, Harumi ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Food protein induced enterocolitis syndrome (FPIES); IgE mediated food allergy (IFA); Non IgE mediated food allergy (NFA)

Indexed keywords

C TYPE LECTIN; CATHELICIDIN; CD103 ANTIGEN; CHEMOKINE RECEPTOR CCR9; CYTOKINE; DEFENSIN; DEXTRAN SULFATE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; KERATINOCYTE GROWTH FACTOR; LECTIN; LYSOZYME; MICRORNA; MUCIN; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; PATTERN RECOGNITION RECEPTOR; POLYPEPTIDE ANTIBIOTIC AGENT; RETINOIC ACID; RETINOL; T LYMPHOCYTE RECEPTOR; TOLL LIKE RECEPTOR; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANGIOGENESIS; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL FUNCTION; CLINICAL FEATURE; COLITIS; CYTOKINE PRODUCTION; DENDRITIC CELL; DRUG METABOLISM; FOOD ALLERGY; GAMMA DELTA T LYMPHOCYTE; HOMEOSTASIS; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; IMMUNOREGULATION; INNATE IMMUNITY; INTESTINE; INTESTINE EPITHELIUM CELL; INTESTINE LYMPHATIC TISSUE; INTESTINE MUCOSA; MEDIATOR; MESENTERY LYMPH NODE; MUCOSAL IMMUNITY; NON IGE MEDIATED FOOD ALLERGY; NONHUMAN; PEYER PATCH; PROTEIN EXPRESSION; PROTEIN SECRETION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH17 CELL;

FOOD; FOOD HYPERSENSITIVITY; HOMEOSTASIS; HUMANS; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN E; IMMUNOMODULATION; INTESTINES; METAGENOME; PROBIOTICS;

EID: 84867692096     PISSN: 18715281     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152812803250971     Document Type: Article

References (147)

1. Mehr, S.S.; Kakakios, A.M.: Kemp, A.S. Rice: a common and severe cause of food protein-induced enterocolitis syndrome. Arch. Dis. Child., 2009, 94, 220-223.
2. Nowak-Wegrzyn, A; Muraro, A. Food protein-induced enterocolitis syndrome. Curr. Opin. Allergy Clin. Immunol., 2009, 9, 371-377.
3. Leonard, S.A.; Nowak-Wegrzyn, A. Food protein-induced enterocolitis syndrome: an update on natural history and review of management. Ann. Allergy. Asthma Immunol., 2011, 107, 95-101.
4. Nomura, I.; Morita, H.; Hosokawa, S.; Hoshina, H.; Fukuie, T.; Watanabe, M.; Ohtsuka, Y.; Shoda, T.; Terada, A.; Takamasu, T.; Arai, K.; Ito, Y.; Ohya, Y.; Saito, H.; Matumoto, K. Four distinct subtypes of non-IgE-mediated gastrointestinal food allergies in neonates and infants, distinguished by their initial symptoms. J. Allergy Clin. Immunol., 2011, 127, 685-688 e681-688.
5. Sicherer, S.H.; Sampson, H.A. Food allergy. J. Allergy Clin. Immunol., 2010, 125, S116-125.
6. Maloy, K.J.; Powrie, F. Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature, 2011, 474, 298-306.
7. Artis, D. Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut. Nat. Rev. Immunol., 2008, 8, 411-420.
8. Hooper, L.V.; Macpherson, A.J. Immune adaptations that maintain homeostasis with the intestinal microbiota. Nat. Rev. Immunol., 2010, 10, 159-169.
9. Vaishnava, S.; Yamamoto, M.; Severson, K.M.; Ruhn, K.A.; Yu, X.; Koren, O.; Ley, R.; Wakeland, E.K.; Hooper, L.V. The antibacterial lectin RegIIIgamma promotes the spatial segregation of microbiota and host in the intestine. Science, 2011, 334, 255-258.
10. Koslowski, M.J.; Beisner, J.; Stange, E.F.; Wehkamp, J. Innate antimicrobial host defense in small intestinal Crohn's disease. Int. J. Med. Microbiol., 2010, 300, 34-40.
11. Obata, Y.; Takahashi, D.; Ebisawa, M.; Kakiguchi, K.; Yonemura, S.; Jinnohara, T.; Kanaya, T.; Fujimura, Y.; Ohmae, M.; Hase, K.; Ohno, H. Epithelial cell-intrinsic notch signaling plays an essential role in the maintenance of gut immune homeostasis. J. Immunol., 2012, 188, 2427-2436.
12. Kaser, A.; Martinez-Naves, E.; Blumberg, R.S. Endoplasmic reticulum stress: implications for inflammatory bowel disease pathogenesis. Curr. Opin. Gastroenterol., 2010, 26, 318-326.
13. Taylor, B.C.; Zaph, C.; Troy, A.E.; Du, Y.; Guild, K.J.; Comeau, M.R.; Artis, D. TSLP regulates intestinal immunity and inflammation in mouse models of helminth infection and colitis. J. Exp. Med., 2009, 206, 655-667.
14. Biton, M.; Levin, A.; Slyper, M.; Alkalay, I.; Horwitz, E.; Mor, H.; Kredo-Russo, S.; Avnit-Sagi, T.; Cojocaru, G.; Zreik, F.; Bentwich, Z.; Poy, M.N.; Artis, M.N.; Walker, M.D.; Hornstein, E.; Pikarsky, E.; Ben-Meriah, Y. Epithelial microRNAs regulate gut mucosal immunity via epithelium-T cell crosstalk. Nat. Immunol., 2011, 12, 239-246.
15. Vaishnava, S.; Behrendt, C.L.; Ismail, A.S.; Eckmann, L.; Hooper, L.V. Paneth cells directly sense gut commensals and maintain homeostasis at the intestinal host-microbial interface. Proc. Natl. Acad. Sci. USA, 2008, 105, 20858-20863.
16. Cario, E. Toll-like receptors in inflammatory bowel diseases: a decade later. Inflamm. Bowel Dis., 2010, 16, 1583-1597.
17. Fukata, M.; Hernandez, Y.; Conduah, D.; Cohen, J.; Chen, A.; Breglio, K.; Goo, T.; Hsu, D.; Xu, R.; Abreu, M.T. Innate immune signaling by Toll-like receptor-4 (TLR4) shapes the inflammatory microenvironment in colitis-associated tumors. Inflamm. Bowel Dis., 2009, 15, 997-1006.
18. Abreu, M.T. Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function. Nat. Rev. Immunol., 2010, 10, 131-144.
19. Strober, W.; Murray, P.J.; Kitani, A.; Watanabe, T. Signaling pathways and molecular interactions of NOD1 and NOD2. Nat. Rev. Immunol., 2006, 6, 9-20.
20. Persson, E.K.; Jaensson, E.; Agace, W.W. The diverse ontogeny and function of murine small intestinal dendritic cell/macrophage subsets. Immunobiology, 2010, 215, 692-697.
21. Scott, C.L.; Aumeunier, A.M.; Mowat, A.M. Intestinal CD103+ dendritic cells: master regulators of tolerance? Trends Immunol., 2011, 32, 412-419.
22. Benson, M.J.; Pino-Lagos, K.; Rosemblatt, M.; Noelle, R.J. Alltrans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of costimulation. J. Exp. Med., 2007, 204, 1765-1774.
23. Kang, S.G.; Lim, H.W.; Andrisani, O.M.; Broxmeyer, H.E.; Kim, C.H. Vitamin A metabolites induce gut-homing FoxP3+ regulatory T cells. J. Immunol., 2007, 179, 3724-3733.
24. Johansson-Lindbom, B.; Agace, W.W. Generation of gut-homing T cells and their localization to the small intestinal mucosa. Immunol. Rev., 2007, 215, 226-242.
25. Matteoli, G.; Mazzini, E.; Iliev, I.D.; Mileti, E.; Fallarino, F.; Puccetti, P.; Chieppa, M.; Rescigno, M. Gut CD103+ dendritic cells express indoleamine 2,3-dioxygenase which influences T regulatory/T effector cell balance and oral tolerance induction. Gut, 2010, 59, 595-604.
26. Coombes, J.L.; Siddiqui, K.R.; Arancibia-Carcamo, C.V.; Hall, J.; Sun, C.M.; Belkaid, Y.; Powrie, F. A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J. Exp. Med., 2007, 204, 1757-1764.
27. Mucida, D.; Pino-Lagos, K.; Kim, G.; Nowak, E.; Benson, M.J.; Kronenberg, M.; Noelle, R.J.; Cheroutre, H. Retinoic acid can directly promote TGF-beta-mediated Foxp3(+) Treg cell conversion of naive T cells. Immunity, 2009, 30, 471-472.
28. Kleijwegt, F.S.; Laban, S.; Duinkerken, G.; Joosten, A.M.; Koeleman, B.P.; Nikolic, T.; Roep, B.O. Transfer of regulatory properties from tolerogenic to proinflammatory dendritic cells via induced autoreactive regulatory T cells. J. Immunol., 2011, 187, 6357-6364.
29. Agace, W.W.; Persson, E.K. How vitamin A metabolizing dendritic cells are generated in the gut mucosa. Trends Immunol., 2012, 33, 42-48.
30. Iliev, I.D.; Spadoni, I.; Mileti, E.; Matteoli, G.; Sonzogni, A.; Sampietro, G.M.; Foschi, D.; Caprioli, F.; Viale, G.; Rescigno, M. Human intestinal epithelial cells promote the differentiation of tolerogenic dendritic cells. Gut, 2009, 58, 1481-1489.
31. Weng, Y.; Sun, J.; Wu, Q.; Pan, J. Regulatory effects of vasoactive intestinal peptide on the migration of mature dendritic cells. J. Neuroimmunol., 2007, 182, 48-54.
32. Delgado, M.; Gonzalez-Rey, E.; Ganea, D. The neuropeptide vasoactive intestinal peptide generates tolerogenic dendritic cells. J. Immunol., 2005, 175, 7311-7324.
33. Gonzalez-Rey, E.; Delgado, M. Therapeutic treatment of experimental colitis with regulatory dendritic cells generated with vasoactive intestinal peptide. Gastroenterology, 2006, 131, 1799-1811.
34. Izcue, A.; Coombes, J.L.; Powrie, F. Regulatory lymphocytes and intestinal inflammation. Annu. Rev. Immunol., 2009, 27, 313-338.
35. Zhou, L.; Chong, M.M.; Littman, D.R. Plasticity of CD4+ T cell lineage differentiation. Immunity, 2009, 30, 646-655.
36. Sun, C.M.; Hall, J.A.; Blank, R.B.; Bouladoux, N.; Oukka, M.; Mora, J.R.; Belkaid, Y. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J. Exp. Med., 2007, 204, 1775-1785.
37. Hall, J.A.; Grainger, J.R.; Spencer, S.P.; Belkaid, Y. The role of retinoic acid in tolerance and immunity. Immunity, 2011, 35, 13-22.
38. Collins, C.B.; Aherne, C.M.; Kominsky, D; McNamee, E.N.; Lebsack, M.D.; Eltzschig, H.; Jedlicka, P.; Rivera-Nieves. Retinoic acid attenuates ileitis by restoring the balance between T-helper 17 and T regulatory cells. J. Gastroenterology, 2011, 141, 1821-1831.
39. Josefowicz, S.Z.; Niec, R.E.; Kim, H.Y.; Treuting P.; Chinen, T.; Zheng, Y.; Umetsu, D.T.; Rudensky, A.Y. Retinoic acid attenuates ileitis by restoring the balance between T-helper 17 and T regulatory cells. Nature, 2012, 482, 395-399.
40. Bian, Z.; Guo, Y.; Ha, B.; Zen, K.; Liu, Y. Regulation of the inflammatory response: enhancing neutrophil infiltration under chronic inflammatory conditions. J. Immunol. 2012, 188, 844-853.
41. Stange, J.; Hepworth, M.R.; Rausch, S.; Zajic, L.; Kuhl, A.A.; Uyttenhove, C.; Renauld, J.C.; Hartmann, S.; Lucius, R. IL-22 Mediates Host Defense against an Intestinal Intracellular Parasite in the Absence of IFN-gamma at the Cost of Th17-Driven Immunopathology. J. Immunol., 2012, 188, 2410-2418.
42. Waterfield, M.; Anderson, M.S. Clues to immune tolerance: the monogenic autoimmune syndromes. Ann. N. Y. Acad. Sci. 2010, 1214, 138-155.
43. O'Garra, A.; Vieira, P. T(H)1 cells control themselves by producing interleukin-10. Nat. Rev. Immunol., 2007, 7, 425-428.
44. McGeachy, M.J.; Bak-Jensen, K.S.; Chen, Y.; Tato, C.M.; Blumenschein, W.; McClanahan, T.; Cua, D.J. TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nat. Immunol., 2007, 8,1390-1397.
45. Maynard, C.L.; Harrington, L.E.' Janowski, K.M.; Oliver, J.R.; Zindl, C.L.; Rudensky, A.Y.; Weaver, C.T. Regulatory T cells expressing interleukin 10 develop from Foxp3+ and Foxp3-precursor cells in the absence of interleukin 10. Nat. Immunol., 2007, 8, 931-941.
46. Schietinger, A.; Delrow, J.J.; Basom, R.S.; Blattman, J.N.; Greenberg, P.D. Rescued tolerant CD8 T cells are preprogrammed to reestablish the tolerant state. Science, 2012, 335, 723-727.
47. Nanno, M.; Shiohara, T.; Yamamoto, H.; Kawakami, K.; Ishikawa, H. gammadelta T cells: firefighters or fire boosters in the front lines of inflammatory responses. Immunol. Rev., 2007, 215, 103-113.
48. Bhagat, G.; Naiyer, A.J.; Shah, J.G.; Harper, J.; Jabri, B.; Wang, T.C.; Green, P.H.; Manavalan, J.S. Small intestinal CD8+TCRgammadelta+NKG2A+ intraepithelial lymphocytes have attributes of regulatory cells in patients with celiac disease. J. Clin. Invest., 2008, 118, 281-293.
49. Zeissig, S.; Kaser, A.; Dougan, S.K.; Nieuwenhuis, E.E.; Blumberg, R.S. Role of NKT cells in the digestive system. III. Role of NKT cells in intestinal immunity. Am. J. Physiol. Gastrointest. Liver Physiol., 2007, 293, G1101-1105.
50. Trop, S.; Ilan, Y. NK 1.1+ T cell: a two-faced lymphocyte in immune modulation of the IL-4/IFN-gamma paradigm. J. Clin. Immunol. 2002, 22, 270-280.
51. Heller, F.; Fuss, I.J.; Nieuwenhuis, E.E.; Blumberg. R.S.; Strober. W. Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells. Immunity, 2002, 17, 629-638.
52. Pesu, M.; Watford, W.T.; Wei, L.; Xu, L.; Fuss, I.; Strober, W.; Andersson, J.; Shevach, E.M.; Quezado, M.; Bouladoux, N.; Roebroek, A.; Belkaid, Y.; Creemers, J.; O'Shoa, J.J. T-cellexpressed proprotein convertase furin is essential for maintenance of peripheral immune tolerance. Nature, 2008, 455, 246-250.
53. Fantini, M.C.; Rizzo, A.; Fina, D.; Caruso, R.; Sarra, M.; Stolfi, C.; Becker, C.; Macdonald, T.T.; Pallone, F.; Neurath, M.F.; Monteleone, G. Smad7 controls resistance of colitogenic T cells to regulatory T cell-mediated suppression. Gastroenterology, 2009, 136, 1308-1316, e1301-1303.
54. Fritz, J.H.; Rojas, O.L.; Simard, N.; McCarthy, D.D.; Hapfelmeier, S.; Rubino, S.; Robertson, S.J.; Larijani, M.; Gosselin, J.; Ivanov, I.I.; Martin, A.; Casellas, R.; Philpott, D. J; Girardin, S.E.; McCoy, K.D.; Macpherson, A.J.; Paige, C.J.; Gommerman, J.L. Acquisition of a multifunctional IgA+ plasma cell phenotype in the gut. Nature, 2012, 481, 199-203.
55. Kuhn, R.; Lohler, J.; Rennick, D.; Rajewsky, K.; Muller, W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell, 1993, 75, 263-274.
56. Moore, K.W.; de Waal Malefyt, R.; Coffman, R.L.; O'Garra, A. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 2001, 19, 683-765.
57. Glocker, E.O.; Kotlarz, D.; Boztug, K.; Gertz, E.M.; Schaffer, A.A.; Noyan, F.; Perro, M.; Diestelhorst, J.; Allroth, A.; Murugan, D.; Hatscher, N.; Pfeifer, D; Sykara, K.W.; Souer, M.; Kreipe, H.; Lacher, M; Mustede, R.; Woellner, C.; Baumann, U., Salzer, U.; Koletzko, S.; Shah, N.; Segal, A.N.; Sauerbrey, A.; Buderus, S.; Snapper, S.B.; Grimbacher, B.; Kleia, C. Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. N. Engl. J. Med., 2009, 361, 2033-2045.
58. Mazmanian, S.K.; Round, J.L.; Kasper, D.L. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature, 2008, 453, 620-625.
59. Griffin, D.O.; Holodick, N.E.; Rothstein, T.L. Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20+ CD27+ CD43+ CD70. J. Exp. Med., 2011, 208, 67-80.
60. Aimanianda, V.; Haensler, J.; Lacroix-Desmazes, S.; Kaveri, S.V.; Bayry, J. Novel cellular and molecular mechanisms of induction of immune responses by aluminum adjuvants. Trends Pharmacol. Sci., 2009, 30,287-295.
61. Kaveri, S.V.; Silverman, G.J.; Bayry, J. Natural IgM in immune equilibrium and harnessing their therapeutic potential. J Immunol., 2012, 188, 939-945.
62. Manderson, A.P.; Botto, M.; Walport, M.J. The role of complement in the development of systemic lupus erythematosus. Annu. Rev. Immunol., 2004, 22, 431-456.
63. Chen, Y.; Park, Y.B.; Patel, E.; Silverman, G.J. IgM antibodies to apoptosis-associated determinants recruit C1q and enhance dendritic cell phagocytosis of apoptotic cells. J. Immunol. 2009, 182, 6031-6043.
64. Chen, Y.; Khanna, S.; Goodyear, C.S.; Park, Y.B.; Raz, E.; Thiel, S.; Gronwall, C.; Vas, J.; Boyle, D.L.; Corr, M.; Kono, D. H; Silverman, G.J. Regulation of dendritic cells and macrophages by an anti-apoptotic cell natural antibody that suppresses TLR responses and inhibits inflammatory arthritis. J. Immunol., 2009, 183, 1346-1359.
65. Lobo, P.I.; Bajwa, A.; Schlegel, K.H.; Vengal, J.; Lee, S.J.; Huang, L.; Ye, H.; Deshmukh, U.; Wang, T.; Pei, H.; Okusa, M.D. Natural IgM Anti-Leukocyte Autoantibodies Attenuate Excess Inflammation Mediated by Innate and Adaptive Immune Mechanisms Involving Th-17. J. Immunol., 2012, 188, 1675-1685.
66. Schwartz-Albiez, R.; Laban, S.; Eichmuller, S.; Kirschfink, M. Cytotoxic natural antibodies against human tumours: an option for anti-cancer immunotherapy? Autoimmun. Rev., 2008, 7, 491-495.
67. Norrby-Teglund, A.; Haque, K.N.; Hammarstrom, L. Intravenous polyclonal IgM-enriched immunoglobulin therapy in sepsis: a review of clinical efficacy in relation to microbiological aetiology and severity of sepsis. J. Intern. Med., 2006, 260, 509-516.
68. Fattal, I.; Shental, N.; Mevorach, D.; Anaya, J.M.; Livneh, A.; Langevitz, P.; Zandman-Goddard, G.; Pauzner, R.; Lerner, M.; Blank, M.; Hinacapie, M.E.; Gafter, U.; Maparstek, Y.; Shoenfeld, Y.; Domany, E.; Cohen, Z.R. An antibody profile of systemic lupus erythematosus detected by antigen microarray. Immunology, 2010, 130, 337-343.
69. Tsuji, M.; Komatsu, N.; Kawamoto, S.; Suzuki, K.; Kanagawa, O.; Honjo, T.; Hori, S.; Fagarasan, S. Preferential generation of follicular B helper T cells from Foxp3+ T cells in gut Peyer's patches. Science, 2009, 323,1488-1492.
70. Ha, S.A.; Tsuji, M.; Suzuki, K.; Meek, B.; Yasuda, N.; Kaisho, T.; Fagarasan, S. Regulation of B1 cell migration by signals through Toll-like receptors. J. Exp. Med., 2006, 203, 2541-2550.
71. Sutherland, D.B.; Fagarasan, S. IgA synthesis: a form of functional immune adaptation extending beyond gut. Curr. Opin. Immunol., 2012, 24, 1-8.
72. Shulzhenko, N.; Morgun, A.; Hsiao, W.; Battle, M.; Yao, M.; Gavrilova, O.; Orandle, M.; Mayer, L.; Macpherson, A.J.; McCoy, K.D.; Fraser-Ligett, E.; Matzinger, P. Crosstalk between B lymphocytes, microbiota and the intestinal epithelium governs immunity versus metabolism in the gut. Nat. Med., 2011, 17, 1585-1593.
73. Ferreira, R.C.; Pan-Hammarstrom, Q.; Graham, R.R.; Gateva, V.; Fontan, G.; Lee, A.T.; Ortmann, W.; Urcelay, E.; Fernandez-Arquero, M.; Nunez, C.; Jorgensen, G.; Ludviksson, B.R.; Koskinen, S.; Haimila, K.; Clark, H.F.; Klareskog, L.; Gregersen, P.K.; Behrens, T.W.; Hammastrom, L. Association of IFIH1 and other autoimmunity risk alleles with selective IgA deficiency. Nat. Genet., 2010, 42, 777-780.
74. Arumugam, M.; Raes, J,; Pelletier, E,; Le Paslier, D.; Yamada, T.; Mende, D.R.; Fernandes, G.R.; Tap, J.; Bruls, T.; Batto, J.M.; et al. Enterotypes of the human gut microbiome. Nature, 2011, 473, 174-180.
75. Wu, G.D.; Chen, J.; Hoffmann, C,; Bittinger, K.; Chen, Y.Y.; Keilbaugh, S.A.; Bewtra, M.; Knights, D.; Walters, W.A.; Knight, R.; Sinha, R.; Gilroy, E.; Gupta, K.; Baldassano, R.; Nassel, L.; Li, H.; Bushman, F.D.; Lewis, J.D. Linking long-term dietary patterns with gut microbial enterotypes. Science, 2011, 334, 105-108.
76. Muegge, B.D.; Kuczynski, J.; Knights, D.; Clemente, J.C.; Gonzalez, A.; Fontana, L.; Henrissat, B.; Knight, R.; Gordon, J.I. Diet drives convergence in gut microbiome functions across mammalian phylogeny and within humans. Science, 2011, 332, 970-974.
77. Faith, J.J.; McNulty, N.P.; Rey, F.E.; Gordon, J.I. Predicting a human gut microbiota's response to diet in gnotobiotic mice. Science, 2011, 333, 101-104.
78. Abrahamsson, T.R.; Jakobsson, H.E.; Andersson, A.F.; Bjorksten, B.; Engstrand, L.; Jenmalm, M.C. Low diversity of the gut microbiota in infants with atopic eczema. J. Allergy Clin. Immunol., 2012, 129, 434-440 e432.
79. van Nimwegen, F. A,; Penders, J.; Stobberingh, E.E.; Postma, D.S.; Koppelman, G.H.; Kerkhof, M.; Reijmerink, N.E.; Dompeling, E.; van den Brandt, P.A.; Ferreira, I.; Mommers, M.; Thijs, C. Mode and place of delivery, gastrointestinal microbiota, and their influence on asthma and atopy. J. Allergy Clin. Immunol., 2011, 128, 948-955 e941-943.
80. Fava, F.; Danese, S. Intestinal microbiota in inflammatory bowel disease: friend of foe? World J. Gastroenterol., 2011, 17, 557-566.
81. Stecher, B.; Robbiani, R.; Walker, A.W.; Westendorf, A.M.; Barthel, M.; Kremer, M.; Chaffron, S.; Macpherson, A.J.; Buer, J.; Parkhill, J.; Dougan, G.; Von Menning, C.; Hardt, W.D. Salmonella enterica serovar typhimurium exploits inflammation to compete with the intestinal microbiota. PLoS. Biol., 2007, 5, 2177-2189.
82. Lee, Y.K.; Mazmanian, S.K. Has the microbiota played a critical role in the evolution of the adaptive immune system? Science, 2010, 330, 1768-1773.
83. Lupp, C.; Robertson, M.L.; Wickham, M.E.; Sekirov, I.; Champion, O.L.; Gaynor, E.C.; Finlay, B.B. Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. Cell Host Microbe., 2007, 2, 119-129.
84. Smith, K.; McCoy, K.D.; Macpherson, A.J. Use of axenic animals in studying the adaptation of mammals to their commensal intestinal microbiota. Semin. Immunol., 2007, 19, 59-69.
85. Esplugues, E.; Huber, S.; Gagliani, N.; Hauser, A.E.; Town, T.; Wan, Y.Y.; O'Connor, W. Jr.; Rongvaux, A.; Van Rooijen, N.; Haberman, A.M.; Iwakurak, Y.; Kuchroo, V.K.; Bluestone, J.A.; Herald, K.C.; Flavell, R.A. Control of TH17 cells occurs in the small intestine. Nature, 2011, 475, 514-518.
86. Atarashi, K.; Nishimura, J.; Shima, T.; Umesaki, Y.; Yamamoto, M.; Onoue, M.; Yagita, H.; Ishii, N.; Evans, R.; Honda, K.; Takeda, K. ATP drives lamina propria T(H)17 cell differentiation. Nature, 2008, 455, 808-812.
87. Ivanov, I.I.; Atarashi, K.; Manel, N.; Brodie, E.L.; Shima, T.; Karaoz, U.; Wei, D.; Goldfarb, K.C.; Santee, C.A.; Lynch, S.V.; Tanoue, T.; Imaoka, A.; Itoh, K.; Takeda, K.; Umesaki, Y.; Honda, K.; Litterman, D.R. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell, 2009, 139, 485-498.
88. Sokol, H.; Pigneur, B.; Watterlot, L.; Lakhdari, O.; Bermudez-Humaran, L.G.; Gratadoux, J.J.; Blugeon, S.; Bridonneau, C.; Furet, J.P.; Corthier, G.; Grangette, C.; Vasquez, N.; Pochant, P.; Thomas, G.; Blottiere, H. M; Dore, J.; Marteau, P.; Sekski, P.; Langella, P. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc. Natl. Acad. Sci. USA, 2008, 105, 16731-16736.
89. Mazmanian, S.K.; Liu, C.H.; Tzianabos, A.O.; Kasper, D.L. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell, 2005, 122,107-118.
90. Round, J.L.; Mazmanian, S.K. Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc. Natl. Acad. Sci. U S A, 2010, 107, 12204-12209.
91. Round, J.L.; Lee, S.M.; Li, J.; Tran, G.; Jabri, B.; Chatila, T.A.; Mazmanian, S.K. The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota. Science, 2011, 332, 974-977.
92. Atarashi, K,; Tanoue, T.; Shima, T.; Imaoka, A.; Kuwahara, T.; Momose, Y.; Cheng, G.; Yamasaki, S.; Saito, T.; Ohba, Y.; Taniguchi, T.; Takeda, K.; Hori, S.; Ivonov, I.I.; Umesaki, Y.; Itoh, K.; Honda, K. Induction of colonic regulatory T cells by indigenous Clostridium species. Science, 2011, 331, 337-341.
93. Lochner, M.; Berard, M,; Sawa, S.; Hauer, S.; Gaboriau-Routhiau, V.; Fernandez, T.D.; Snel, J.; Bousso, P.; Cerf-Bensussan, N.; Eberl, G. Restricted microbiota and absence of cognate TCR antigen leads to an unbalanced generation of Th17 cells. J. Immunol., 2011, 186, 1531-1537.
94. Ochoa-Reparaz, J.; Mielcarz, D.W.; Wang, Y.; Begum-Haque, S.; Dasgupta, S.; Kasper, D.L.; Kasper, L.H. A polysaccharide from the human commensal Bacteroides fragilis protects against CNS demyelinating disease. Mucosal Immunol., 2010, 3, 487-495.
95. Ochoa-Reparaz, J.; Mielcarz, D.W.; Haque-Begum, S.; Kasper, L.H. Induction of a regulatory B cell population in experimental allergic encephalomyelitis by alteration of the gut commensal microflora. Gut Microbes, 2010, 1, 103-108.
96. Wu, H.J.; Ivanov, I.I.; Darce, J.; Hattori, K,; Shima, T.; Umesaki, Y.; Littman, D.R.; Benoist, C.; Mathis, D. Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. Immunity, 2010, 32, 815-827.
97. Lee, Y.K.; Menezes, J.S.; Umesaki, Y.; Mazmanian, S.K. Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis. Proc, Natl, Acad, Sci, U S A, 2011, 108(Suppl 1), 4615-4622.
98. Berer, K.; Mues, M.; Koutrolos, M.; Rasbi, Z.A.; Boziki, M.; Johner, C.; Wekerle, H.; Krishnamoorthy, G. Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination. Nature, 2011, 479, 538-541.
99. Kuss, S.K.; Best, G.T.; Etheredge, C.A.; Pruijssers, A.J.; Frierson, J.M.; Hooper, L.V.; Dermody, T.S.; Pfeiffer, J.K. Intestinal microbiota promote enteric virus replication and systemic pathogenesis. Science, 2011, 334, 249-252.
100. Lathrop, S.K.; Bloom, S.M.; Rao, S.M.; Nutsch, K.; Lio, C.W.; Santacruz, N.; Peterson, D.A.; Stappenbeck, T.S.; Hsieh, C.S. Peripheral education of the immune system by colonic commensal microbiota. Nature, 2011, 478, 250-254.
101. Ochoa-Reparaz, J.; Mielcarz, D.W.; Ditrio, L.E.; Burroughs, A.R.; Foureau, D.M.; Haque-Begum, S.; Kasper, L.H. Role of gut commensal microflora in the development of experimental autoimmune encephalomyelitis. J. Immunol., 2009, 183, 6041-6050.
102. Schiffer, C.; Lalanne, A.I.; Cassard, L.; Mancardi, D.A.; Malbec, O.; Bruhns, P.; Dif, F,; Daeron, M. A strain of Lactobacillus casei inhibits the effector phase of immune inflammation. J. Immunol., 2011, 187, 2646-2655.
103. Ly, N.P.; Litonjua, A.; Gold, D.R.; Celedon, J.C. Gut microbiota, probiotics, and vitamin D: interrelated exposures influencing allergy, asthma, and obesity? J. Allergy Clin. Immunol., 2011, 127, 1087-1094.
104. Strowig, T.; Henao-Mejia, J.; Elinav, E.; Flavell, R. Inflammasomes in health and disease. Nature, 2012, 481, 278-286.
105. Elinav, E.; Strowig, T.; Kau, A.L.; Henao-Mejia, J.; Thaiss, C.A.; Booth, C.J.; Peaper, D.R.; Bertin, J.; Eisenbarth, S.C.; Gordon, J.I.; Flavell, R.A. NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell, 2011, 145, 745-757.
106. Henao-Mejia, J.; Elinav, E.; Jin, C.; Hao, L.; Mehal. W.Z.; Strowig, T.; Thaiss, C.A.; Kau, A.L.; Eisenbarth, S.C.; Jurczak, M.J.; Camporez, J. P; Shulman, G.I.; Gordon, J.I.; Hoffman, H.M.; Flavell, R.A. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature, 2012, 482, 179-185.
107. Jackson, J.A.; Friberg, I.M.; Little, S.; Bradley, J.E. Review series on helminths, immune modulation and the hygiene hypothesis: immunity against helminths and immunological phenomena in modern human populations: coevolutionary legacies? Immunology, 2009, 126, 18-27.
108. Hayes, K.S.; Bancroft, A.J.; Goldrick, M.; Portsmouth, C.; Roberts, I.S.; Grencis, R.K. Exploitation of the intestinal microflora by the parasitic nematode Trichuris muris. Science, 2010, 328, 1391-1394.
109. Panzer, M.; Sitte, S.; Wirth, S.; Drexler, I.; Sparwasser, T.; Voehringer, D. Rapid in vivo conversion of effector T cells into Th2 cells during helminth infection. J. Immunol., 2012, 188, 615-623.
110. Hubner, M.P.; Shi, Y.; Torrero. M.N.; Mueller, E.; Larson, D.; Soloviova, K.; Gondorf, F.; Hoerauf, A.; Killoran, K.E.; Stocker, J.T.; Davies, S.J.; Tarbell, K.V.; Mitre, E. Helminth protection against autoimmune diabetes in nonobese diabetic mice is independent of a type 2 immune shift and requires TGF-beta. J. Immunol. 2012, 188, 559-568.
111. Hussaarts, L.; van der Vlugt, L.E.; Yazdanbakhsh, M.; Smits, H.H. Regulatory B-cell induction by helminths: implications for allergic disease. J. Allergy Clin. Immunol., 2011, 128, 733-739.
112. Tilg, H. Diet and intestinal immunity. N. Engl. J. Med., 2012, 366, 181-183.
113. Kiss, E.A.; Vonarbourg, C.; Kopfmann, S.; Hobeika, E.; Finke, D.; Esser, C.; Diefenbach, A. Natural aryl hydrocarbon receptor ligands control organogenesis of intestinal lymphoid follicles. Science, 2011, 334, 1561-1565.
114. Li, Y.; Innocentin, S.; Withers, D.R.; Roberts, N.A.; Gallagher, A.R.; Grigorieva, E.F.; Wilhelm, C.; Veldhoen, M. Exogenous stimuli maintain intraepithelial lymphocytes via aryl hydrocarbon receptor activation. Cell, 2011, 147, 629-640.
115. Sonnenberg, G.F.; Fouser, L.A.; Artis, D. Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22. Nat. Immunol., 2011, 12, 383-390.
116. Monteleone, I.; Rizzo, A.; Sarra, M.; Sica, G.; Sileri, P.; Biancone, L.; MacDonald, T.T.; Pallone, F.; Monteleone, G. Aryl hydrocarbon receptor-induced signals up-regulate IL-22 production and inhibit inflammation in the gastrointestinal tract. Gastroenterology, 2011, 141, 237-248, 248 e231.
117. Opitz, C.A., Litzenburger, U.M.; Sahm, F.; Ott, M.; Tritschler, I.; Trump, S.; Schumacher, T.; Jestaedt, L.; Schrenk, D.; Weller, M.; Jugold, M.; Guillemin, G.J.; Miller, C.L.; Lutz, C.; Radlwimmer, B.; Lehmann, I.; von Deimling, A.; Wide, A.; Platten, M. An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor. Nature, 2011, 478, 197-203.
118. Kranich, J,; Maslowski, K.M.; Mackay, C.R. Commensal flora and the regulation of inflammatory and autoimmune responses. Semin. Immunol., 2011, 23, 139-145.
119. De Filippo, C.; Cavalieri, D.; Di Paola, M.; Ramazzotti, M.; Poullet, J.B.; Massart, S.; Collini, S.; Pieraccini, G.; Lionetti, P. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Pro. c Nat. l Acad. Sci. U S A, 2010, 107, 14691-14696.
120. Maslowski, K.M.; Vieira, A.T.; Ng, A.; Kranich, J.; Sierro, F.; Yu, D.; Schilter, H.C.; Rolph, M.S.; Mackay, F.; Artis, D.; Xavier, R.J.; Teixeira, M. M; Mackay, C.R. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature, 2009, 461, 1282-1286.
121. Wen, L.; Ley, R.E.; Volchkov, P.Y.; Stranges, P.B.; Avanesyan, L.; Stonebraker, A.C.; Hu, C.; Wong, F.S.; Szot, G.L.; Bluestone, J.A.; Gordon, J.I.; Chervonsky, A.V. Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature, 2008, 455, 1109-1113.
122. Vijay-Kumar, M.; Aitken, J.D.; Carvalho, F.A.; Cullender, T.C.; Mwangi, S.; Srinivasan, S.; Sitaraman, S.V.; Knight, R.; Ley, R.E.; Gewirtz, A.T. Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science, 2010, 328, 228-231.
123. Frank, D.N.; St Amand, A.L.; Feldman, R.A.; Boedeker, E.C.; Harpaz, N.; Pace, N.R. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc. Natl. Acad. Sci. U S A, 2007, 104, 13780-13785.
124. Tursi, A.; Brandimarte, G.; Papa, A.; Giglio, A.; Elisei, W.; Giorgetti, G.M.; Forti, G.; Morini, S.; Hassan, C.; Pistoia, M.A.; Modeo, M.E.; Rodino, S.; D'Amico T.; Sebkova, L.; Sacca, N.; Di Giulio, E.; Luzza, F.; Imeneo, M.; Larussa, T.; Di Rossa, S.; Annese, V.; Danese, S.; Gasbarrini, A. Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL#3 as adjunctive to a standard pharmaceutical treatment: a double-blind, randomized, placebo-controlled study. Am. J. Gastroenterol., 2010, 105, 2218-2227.
125. Guandalini, S,; Magazzu, G.; Chiaro, A.; La Balestra, V.; Di Nardo, G.; Gopalan, S.; Sibal, A.; Romano, C.; Canani, R.B.; Lionetti, P.; Setty, M. VSL#3 improves symptoms in children with irritable bowel syndrome: a multicenter, randomized, placebocontrolled, double-blind, crossover study. J. Pediatr. Gastroenterol. Nutr., 2010, 51, 24-30.
126. He, S.M.; Chan, E.; Zhou, S.F. ADME properties of herbal medicines in humans: evidence, challenges and strategies. Curr. Pharm. Des., 2011, 17, 357-407.
127. Kim, Y.S.; Kim, J.J.; Cho, K.H.; Jung, W.S.; Moon, S.K.; Park, E.K.; Kim, D.H. Biotransformation of ginsenoside Rb1, crocin, amygdalin, geniposide, puerarin, ginsenoside Re, hesperidin, poncirin, glycyrrhizin, and baicalin by human fecal microflora and its relation to cytotoxicity against tumor cells. J Microbiol. Biotechnol., 2008, 18, 1109-1114.
128. Lee, H.S.; Kim, M.J. Selective responses of three Ginkgo biloba leaf-derived constituents on human intestinal bacteria. J. Agric. Food Chem., 2002, 50, 1840-1844.
129. Sicherer, S.H.; Eigenmann, P.A.; Sampson, H.A. Clinical features of food protein-induced enterocolitis syndrome. J. Pediatr., 1998, 133, 214-219.
130. Kabuki, T.; Joh, K. Extensively hydrolyzed formula (MA-mi) induced exacerbation of food protein-induced enterocolitis syndrome (FPIES) in a male infant. Allergo. l Int., 2007, 56, 473-476.
131. Ward, C.M.; Geng, L.; Jyonouchi, H. Fetal sensitization to cow's milk protein and wheat: cow's milk protein and wheat-specific TNF-alpha production by umbilical cord blood cells and subsequent decline of TNF-alpha production by peripheral blood mononuclear cells following dietary intervention. Pediatr. Allergy Immunol., 2007, 18, 276-280.
132. Nowak-Wegrzyn, A.; Sampson, H.A.; Wood, R.A.; Sicherer, S.H. Food protein-induced enterocolitis syndrome caused by solid food proteins. Pediatrics, 2003, 111, 829-835.
133. Levy, Y.; Danon, Y.L. Food protein-induced enterocolitis syndrome--not only due to cow's milk and soy. Pediatr. Allergy Immunol., 2003, 14, 325-329.
134. Caubet. J.C.; Nowak-Wegrzyn, A. Food protein-induced enterocolitis to hen's egg. J. Allergy Clin. Immunol., 2011, 128,1386-1388.
135. Coates, R.W.; Weaver, K.R.; Lloyd, R.; Ceccacci, N.; Greenberg, M.R. Food protein-induced enterocolitis syndrome as a cause for infant hypotension. West J. Emerg. Med., 2011, 12, 512-514.
136. Mehr, S.; Kakakios, A.; Frith, K.; Kemp, A.S. Food proteininduced enterocolitis syndrome: 16-year experience. Pediatrics, 2009, 123, e459-464.
137. Katz, Y.; Goldberg, M.R.; Rajuan, N.; Cohen, A.; Leshno, M. The prevalence and natural course of food protein-induced enterocolitis syndrome to cow's milk: a large-scale, prospective populationbased study. J. Allergy Clin. Immunol., 2011, 127, 647-653 e641-643.
138. Hwang, J.B.; Sohn, S.M.; Kim, A.S. Prospective follow-up oral food challenge in food protein-induced enterocolitis syndrome. Arch. Dis. Child., 2009, 94, 425-428.
139. Fogg, M.I.; Brown-Whitehorn, T.A.; Pawlowski, N.A.; Spergel, J.M. Atopy patch test for the diagnosis of food protein-induced enterocolitis syndrome. Pediatr. Allergy Immunol., 2006, 17, 351-355.
140. Caubet, J.C.; Nowak-Wegrzyn, A. Current understanding of the immune mechanisms of food protein-induced enterocolitis syndrome. Expert Rev. Clin. Immunol., 2011, 7, 317-327.
141. Benlounes, N.; Dupont, C.; Candalh, C.; Blaton, M.A.; Darmon, N.; Desjeux, J.F.; Heyman, M. The threshold for immune cell reactivity to milk antigens decreases in cow's milk allergy with intestinal symptoms. J. Allergy Clin. Immunol., 1996, 98, 781-789.
142. Benlounes, N.; Candalh, C.; Matarazzo, P.; Dupont, C,; Heyman, M. The time-course of milk antigen-induced TNF-alpha secretion differs according to the clinical symptoms in children with cow's milk allergy. J. Allergy Clin. Immunol., 1999, 104, 863-869.
143. Chung, H.L.; Hwang, J.B.; Park, J.J.; Kim, S.G. Expression of transforming growth factor beta1, transforming growth factor type I and II receptors, and TNF-alpha in the mucosa of the small intestine in infants with food protein-induced enterocolitis syndrome. J. Allergy Clin. Immunol., 2002, 109, 150-154.
144. Heyman, M.; Darmon, N.; Dupont, C.; Dugas, B.; Hirribaren, A.; Blaton, M.A.; Desjeux. J.F. Mononuclear cells from infants allergic to cow's milk secrete tumor necrosis factor alpha, altering intestinal function. Gastroenterology, 1994, 106, 1514-1523.
145. Karlsson, M.R.; Rugtveit, J.; Brandtzaeg, P. Allergen-responsive CD4+CD25+ regulatory T cells in children who have outgrown cow's milk allergy. J. Exp. Med., 2004, 199, 1679-1688.
146. Mori, F.; Barni, S.; Cianferoni, A.; Pucci, N.; de Martino, M.; Novembre, E. Cytokine expression in CD3+ cells in an infant with food protein-induced enterocolitis syndrome (FPIES): case report. Clin. Dev. Immunol., 2009, 2009, 679381.
147. Frei, R.; Lauener, R.P.; Crameri, R.; O'Mahony, L. Microbiota and dietary interactions-an update to the hygiene hypothesis? Allergy, 2012, 67, 451-461.